Financials
Income statement
| Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.1B | 8.7B | 7.8B | 6.8B |
| Cost of revenue | 5.1B | 5.4B | 5.0B | 5.0B |
| Gross profit | 3.0B | 3.3B | 2.7B | 1.8B |
| Operating expense | ||||
| Research & development | 898M | 888M | 903M | 850M |
| Selling general and admin | 285M | 288M | 295M | 291M |
| Other operating expenses | 7M | -2M | 12M | 10M |
| Operating income | 1.8B | 2.2B | 1.5B | 681M |
| Non operating interest income | ||||
| Income | 108M | 107M | 131M | 136M |
| Expense | 112M | 118M | 136M | 150M |
| Other income expense | -11M | -11M | -12M | 48M |
| Pretax income | 1.8B | 2.2B | 1.5B | 715M |
| Tax provision | 177M | 283M | 623M | 377M |
| Net income | 1.6B | 1.9B | 887M | 332M |
| Basic EPS | 0.2 | 0.3 | 0.1 | 0.1 |
| Diluted EPS | 0.2 | 0.3 | 0.1 | 0.1 |
| Basic average shares | 4.7B | 4.7B | 4.7B | 4.7B |
| Diluted average shares | 4.7B | 4.7B | 4.7B | 4.7B |
| EBITDA | 3.9B | 4.3B | 3.6B | 2.8B |
| Net income from continuing op. | 1.6B | 1.9B | 887M | 332M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |